Okay, I've searched for Senior Director roles in RWE or Epidemiology within the pharmaceutical industry, located in New London County, CT, requiring at least 7 years of experience and a PhD in Epidemiology or a related field. I found 42 positions that match your criteria. You can check them out now.

Sure. Here's the analysis:

Job Analysis:

The Senior Director, Rare Disease, RWE/Epi Team Lead position at Pfizer is fundamentally about spearheading the generation of real-world evidence (RWE) and epidemiologic studies that inform rare disease drug development strategies. This role is critical, as it not only requires leading a team of scientists in executing complex epidemiological research but also necessitates a deep understanding of both the scientific principles at play and the regulatory environment shaping the field. Key responsibilities include authoring and reviewing study protocols and ensuring alignment with Pfizer’s Integrated Evidence Plan, which reflects the need for strategic leadership, cross-functional collaboration, and operational efficiency. Candidates must navigate challenges such as ensuring the quality and timeliness of deliverables, fostering team morale, and integrating RWE insights into broader therapeutic strategies. Success in this role will likely be measured by the quality of studies produced, effectiveness in building partnerships across disciplines, and the ability to influence strategic decisions at high organizational levels.

Company Analysis:

Pfizer stands as a legacy leader in the pharmaceutical industry, celebrated for over 175 years of scientific innovation. The company's commitment to improving health through pioneering research positions it at the forefront of drug development, particularly in niche areas like rare diseases. Understanding Pfizer’s cultural ethos is crucial; it appears to value innovation, collaboration, and a commitment to improving patient outcomes. These values suggest that the environment is dynamic and may be fast-paced, necessitating leaders who can adapt and drive team alignment swiftly. The Senior Director role operates within an expansive matrix, implying significant interdisciplinary collaboration and visibility with leadership. This position is likely viewed as a strategic contributor to Pfizer’s objective of delivering high-value medicines, indicating that candidates will need to see beyond their immediate responsibilities and align their teams' outputs with the broader strategic goals of the organization.

Absolutely. Here are some mock interview questions that could come up:

• Tell me about a time when you had to lead a team through a complex project in the realm of epidemiology.
• Can you provide an example of how you successfully influenced senior leadership on a strategic decision involving RWE?
• Describe a challenge you faced in managing a cross-functional team and how you overcame it.
• What model or approach do you typically use to foster colleague growth within your team?
• How would you approach designing and executing a non-interventional study from start to finish?
• What is your experience with the Integrated Evidence Plan, and how do you ensure studies align with it?
• How would you manage stakeholder expectations while facing tight deadlines on RWE deliverables?
• Imagine you are faced with a regulatory change impacting an RWE study. How would you navigate this situation?
• Why are you interested in working at Pfizer specifically in the context of rare disease research?
• How do your values align with Pfizer's mission to innovate and improve patient outcomes in rare diseases?
• Can you discuss a situation where you had to quickly adapt a research strategy due to emerging data?
• What processes or systems would you establish to optimize the performance of the RWE/Epi team?
• How do you keep abreast of the latest developments in epidemiology and RWE, and how do you apply them in your work?
• What questions do you have about Pfizer’s current strategies for rare disease development?
• How do you envision your leadership style contributing to Pfizer's focus on innovation and collaboration in drug development?